Personalized rTMS for Resistant Depression
Validation of Personalized Antidepressant Treatment by Neuromodulation - Pilot Study
Sponsor: University Hospital, Strasbourg, France
Terminated
The research objectives are achieved, demonstrating the feasibility and superiority of the personalized approach. It was no longer justified to continue the inclusions in this 'proof of concept' type study.
Other terminated trials from University Hospital, Strasbourg, France
- Healthy Control Subjects · Apr 2025
- Cystic Fibrosis-related Diabetes · Phase PHASE4 · Jan 2025
- Kidney Transplant Recipients · Nov 2024
- Diagnosed With Uretral Fibroscopy · Sep 2024
- Patients with Colorectal Cancer · Phase NA · Sep 2024
See all terminations from University Hospital, Strasbourg, France
This NA trial investigates Depressive Disorder and Treatment-Resistant and is currently terminated or withdrawn. University Hospital, Strasbourg, France leads this study, which shows 12 recorded versions since 2016 — indicating substantial longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
12 versions recorded-
Oct 2025 — Present [monthly]
Terminated NA
-
Sep 2024 — Oct 2025 [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Apr 2023 — Jul 2024 [monthly]
Terminated NA
-
May 2022 — Apr 2023 [monthly]
Terminated NA
Status: Recruiting → Terminated
▶ Show 7 earlier versions
-
Jan 2021 — May 2022 [monthly]
Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Recruiting NA
-
May 2019 — Sep 2020 [monthly]
Recruiting NA
-
Jun 2018 — May 2019 [monthly]
Recruiting NA
-
Apr 2018 — Jun 2018 [monthly]
Recruiting NA
-
Oct 2017 — Apr 2018 [monthly]
Recruiting NA
Phase: PHASE1_PHASE2 → NA
-
Jan 2017 — Oct 2017 [monthly]
Recruiting PHASE1_PHASE2
First recorded
May 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- University Hospital, Strasbourg, France
For direct contact, visit the study record on ClinicalTrials.gov .